IL90206A0 - Pharmaceutical compositions for reducing the side effects of tnf - Google Patents

Pharmaceutical compositions for reducing the side effects of tnf

Info

Publication number
IL90206A0
IL90206A0 IL90206A IL9020689A IL90206A0 IL 90206 A0 IL90206 A0 IL 90206A0 IL 90206 A IL90206 A IL 90206A IL 9020689 A IL9020689 A IL 9020689A IL 90206 A0 IL90206 A0 IL 90206A0
Authority
IL
Israel
Prior art keywords
side effects
tnf
reducing
pharmaceutical compositions
tnfs
Prior art date
Application number
IL90206A
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL90206A0 publication Critical patent/IL90206A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paper (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Abstract

Concomitant administration of TNFs with a PAF antagonist allows the unwanted side effects of the TNFs to be reduced and the therapeutic index of the TNFs to be increased.
IL90206A 1988-05-11 1989-05-05 Pharmaceutical compositions for reducing the side effects of tnf IL90206A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3816169A DE3816169A1 (en) 1988-05-11 1988-05-11 USE AND AGENT FOR REDUCING THE SIDE EFFECTS OF TNF

Publications (1)

Publication Number Publication Date
IL90206A0 true IL90206A0 (en) 1989-12-15

Family

ID=6354207

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90206A IL90206A0 (en) 1988-05-11 1989-05-05 Pharmaceutical compositions for reducing the side effects of tnf

Country Status (13)

Country Link
EP (1) EP0341558B1 (en)
JP (1) JP2709139B2 (en)
KR (1) KR900017592A (en)
AT (1) ATE78695T1 (en)
AU (1) AU614607B2 (en)
CA (1) CA1336825C (en)
DE (2) DE3816169A1 (en)
DK (1) DK220789A (en)
ES (1) ES2042864T3 (en)
GR (1) GR3005387T3 (en)
HU (1) HUT52381A (en)
IL (1) IL90206A0 (en)
ZA (1) ZA893259B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3735525C2 (en) * 1987-10-20 1997-02-20 Korth Ruth Maria Method for determining the efficacy of paf-acether receptor antagonists
GB8926611D0 (en) * 1989-11-24 1990-01-17 Xenova Ltd Compound and its use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3786456T2 (en) * 1986-10-16 1994-02-03 Harvard College COMBINATIONS OF NECROSIS TUMOR FACTORS AND ANTI-INFLAMMATORY AGENTS FOR THE TREATMENT OF Vicious AND NON-Vicious DISEASES.

Also Published As

Publication number Publication date
DK220789A (en) 1989-11-12
AU614607B2 (en) 1991-09-05
EP0341558A3 (en) 1990-05-09
JPH0276825A (en) 1990-03-16
ZA893259B (en) 1991-01-30
EP0341558B1 (en) 1992-07-29
JP2709139B2 (en) 1998-02-04
ATE78695T1 (en) 1992-08-15
AU3406489A (en) 1989-11-16
CA1336825C (en) 1995-08-29
EP0341558A2 (en) 1989-11-15
KR900017592A (en) 1990-12-19
DE3816169A1 (en) 1989-11-23
ES2042864T3 (en) 1993-12-16
DK220789D0 (en) 1989-05-05
DE58901920D1 (en) 1992-09-03
HUT52381A (en) 1990-07-28
GR3005387T3 (en) 1993-05-24

Similar Documents

Publication Publication Date Title
AU4519089A (en) Device for aiding in preparation of intravenous therapy
ZA892321B (en) Pharmaceutical composition for systemic transdermal administration
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
IL71967A (en) Drug administration composition
NZ230036A (en) Intravenous pharmaceutical composition comprising cyclosporin
AU4741790A (en) Syringe adapted to prevent needle sticks
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
EP0177329A3 (en) Device for transdermal drug administration
ZA875397B (en) Pharmaceutical composition with analgesic activity
ZA89792B (en) Pharmaceutical compositions with improved stability
MY103872A (en) 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function.
NZ226634A (en) Substituted piperidine derivatives and analgesic and anesthetic compositions
NZ224181A (en) Pyrrolidine derivatives and pharmaceutical compositions
PH31582A (en) Glycoslated cytokins.
JPS6416763A (en) Analgesic composition
IL90206A0 (en) Pharmaceutical compositions for reducing the side effects of tnf
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
GB8812621D0 (en) Pharmaceutical composition containing combination of analgesic agents
ZA888714B (en) Medicament with antiemetic action
CS631190A3 (en) E1 prostaglandin in injection medicinal form
KR900002681A (en) Pharmaceutical composition with synergistic effect
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
IE883395L (en) Medicament with antiemetic action